title: Fine-tuning the effects of T-cell therapy.
abstract: Researchers have engineered molecules called inhibitory chimeric antigen receptors that can help divert off-target responses, better protecting normal tissues from damage caused by some engineered T-cell therapies.
mesh_terms: D064987:Cell- and Tissue-Based Therapy; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism
chemical_list: D011948:Receptors, Antigen, T-Cell